This webinar was recorded live on April 23, 2024.
It is available on demand through April 30, 2025.
Register above for access
Description
This interactive webinar explores the forefront of advancements and practical applications of high sensitivity cardiac troponin assays in Point of Care (POC), particularly in the diagnosis and management of acute coronary syndromes (ACS). Focusing on the impact that these assays have on patient outcomes, the session aims to bridge the gap between emerging science and clinical practice. The speaker, Dr. Fred Apple, will navigate through the latest evidence-based practices, shedding light on crucial aspects such as assay selection criteria, nuanced interpretation of results, and the seamless integration of these assays into clinical workflows. Attendees will gain valuable insights into optimizing the use of POC high sensitivity troponin assays, thereby empowering them to make informed decisions in ACS management.
Target Audience
This activity is designed for physicians, advanced practice professionals (NPs, PAs, RNs, etc.), lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, fellows, residents, and other laboratory professionals working in the fast-paced environment of cardiac emergencies.
Learning Objectives
At the end of this session, participants will be able to:
- Identify the clinical and analytical characteristics of high sensitivity cardiac troponin assays for early diagnosis and risk stratification in acute coronary syndrome (ACS).
- Describe the utilization and interpretation of high sensitivity cardiac troponin assays in various clinical settings, including the challenges of implementing these assays at the POC.
- Review key actions to select, implement, and interpret high sensitivity troponin assays in POC settings.
Faculty
Fred Apple, PhD, DABCC
Professor & Clinical Lab Director
Hennepin Healthcare/HCMC
Minneapolis, MN, USA
Disclosures and Statement of Independence
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Fred Apple, PhD, DABCC
- Honorarium/Expenses: Polymedco
- Consultant Fee: HyTest
- Grant/Research Support: Non-salaried: Abbott Diagnostics, Abbott POC, Roche Diagnostics, Quidel/Ortho. Beckman Coulter, Siemens Healthineers, Becton Dickinson
- Board/Committee Membership/Advisory Board: Werfen, Abbott Vascular
Content Validity
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
Accreditation Statement
This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID #4288. This activity was planned in accordance with ACCENT® Standards and Policies.
Successful Completion Statement
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].